FR2445M - New piperazine derivatives, usable in therapy. - Google Patents

New piperazine derivatives, usable in therapy.

Info

Publication number
FR2445M
FR2445M FR925898A FR925898A FR2445M FR 2445 M FR2445 M FR 2445M FR 925898 A FR925898 A FR 925898A FR 925898 A FR925898 A FR 925898A FR 2445 M FR2445 M FR 2445M
Authority
FR
France
Prior art keywords
usable
therapy
piperazine derivatives
new piperazine
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR925898A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA
Original Assignee
Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB7429/62A external-priority patent/GB984017A/en
Application filed by Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA filed Critical Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA
Application granted granted Critical
Publication of FR2445M publication Critical patent/FR2445M/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR925898A 1962-02-26 1963-02-25 New piperazine derivatives, usable in therapy. Active FR2445M (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7429/62A GB984017A (en) 1962-02-26 1962-02-26 New piperazine derivatives and a process for their preparation
GB4009662 1962-10-23

Publications (1)

Publication Number Publication Date
FR2445M true FR2445M (en) 1964-04-06

Family

ID=87519722

Family Applications (1)

Application Number Title Priority Date Filing Date
FR925898A Active FR2445M (en) 1962-02-26 1963-02-25 New piperazine derivatives, usable in therapy.

Country Status (1)

Country Link
FR (1) FR2445M (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2535718A1 (en) * 1982-11-09 1984-05-11 Sanofi Sa (PIPERAZINYL-1) -2 PYRIMIDINES, THEIR SALTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2535718A1 (en) * 1982-11-09 1984-05-11 Sanofi Sa (PIPERAZINYL-1) -2 PYRIMIDINES, THEIR SALTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0115713A1 (en) * 1982-11-09 1984-08-15 Sanofi S.A. 2-(1-Piperazinyl)-pyrimidines, their salts, process for their preparation and pharmaceutical compositions containing them

Similar Documents

Publication Publication Date Title
FR3380M (en) New anthelmintic preparations, usable in therapy.
FR3257M (en) 1- (5-nitrofurfurylidene-amino) -1,4-tetrahydrothiazine 4,4-dioxide.
FR1749M (en) New piperazine derivatives, usable in therapy.
FR2445M (en) New piperazine derivatives, usable in therapy.
FR2446M (en) New derivatives of piperazine.
FR3137M (en) New δ <4> -7α, 17α-dimethyl-17β-hydroxy-estrene usable in therapy.
FR2936M (en) Piperazine derivatives.
FR2229M (en) Pyrazine derivatives usable as medicaments.
FR2797M (en) New piperidine derivatives.
FR3138M (en) New derivatives of 6-11-dihydrodibenz / b, e / thiepin.
FR3174M (en) New δ-3β17β-dihydroxy-7α17α-dimethyl-19-nor-androstene usable in therapy.
FR1823M (en) Cynarin derivatives.
ES148615Y (en) FOLDING TABLE, PERFECTED.
FR2114M (en) New alkylsulfonyloxy derivatives usable as medicaments.
FR2799M (en) New substituted β-phenylcyclohexylamines useful in therapy.
FR1728M (en) Gastroenterological drug.
FR1739M (en) Gastroenterological drug.
FR3761M (en) New dihydrothieno- [3,4-d] -pyrimidines.
ES160769Y (en) CART-BASKET, PERFECTED.
FR1029M (en) New 17α-isobutyl-androstane-3β, 17β-diol usable in therapy.
FR2873M (en) New anthelmintic preparation, usable in therapy.
ES90836Y (en) PERFECTED GIRDLE-PANTIES.
ES95190Y (en) Decorative figure, perfected
BE618690A (en) Wheelchair.
ES147727Y (en) PERFECTED SAUNA.